A groundbreaking medication , retatrutide, is creating considerable anticipation within the Oz weight loss community. Created by Eli Lilly , this combination GIP and GLP-1 agonist appears to offer more impressive outcomes than existing therapies. Initial clinical trials have shown exceptional dec